AU1329700A - Method of interfering with cell proliferation - Google Patents

Method of interfering with cell proliferation

Info

Publication number
AU1329700A
AU1329700A AU13297/00A AU1329700A AU1329700A AU 1329700 A AU1329700 A AU 1329700A AU 13297/00 A AU13297/00 A AU 13297/00A AU 1329700 A AU1329700 A AU 1329700A AU 1329700 A AU1329700 A AU 1329700A
Authority
AU
Australia
Prior art keywords
interfering
cell proliferation
proliferation
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13297/00A
Inventor
Scott E. Baker
Jonathan C.R. Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northwestern University
Original Assignee
Northwestern University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwestern University filed Critical Northwestern University
Publication of AU1329700A publication Critical patent/AU1329700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1777—Integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU13297/00A 1998-10-30 1999-10-29 Method of interfering with cell proliferation Abandoned AU1329700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10649198P 1998-10-30 1998-10-30
US60106491 1998-10-30
PCT/US1999/025359 WO2000026342A1 (en) 1998-10-30 1999-10-29 Method of interfering with cell proliferation

Publications (1)

Publication Number Publication Date
AU1329700A true AU1329700A (en) 2000-05-22

Family

ID=22311691

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13297/00A Abandoned AU1329700A (en) 1998-10-30 1999-10-29 Method of interfering with cell proliferation

Country Status (2)

Country Link
AU (1) AU1329700A (en)
WO (1) WO2000026342A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6955924B2 (en) 1994-10-04 2005-10-18 Biostratum, Inc. Laminin chains: diagnostic uses
EP1280553A2 (en) * 2000-05-12 2003-02-05 Fibrogen, Inc. Methods of affecting laminin 5 processing
JP2008502588A (en) * 2003-12-12 2008-01-31 ノボ　ノルディスク　アクティーゼルスカブ Laminin-5 modulator and use thereof
US7875277B2 (en) 2004-01-27 2011-01-25 The Dept. of Veterans Affairs Office of The General Counsel Compositions and methods for inhibiting squamous cell carcinoma
US7323551B2 (en) 2004-01-27 2008-01-29 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for inhibiting squamous cell carcinoma
WO2007114851A1 (en) * 2006-04-04 2007-10-11 The Board Of Trustees Of The University Of Illinois Methods and compositions to induce cell death of invasive tumors
EP2291402B1 (en) 2008-06-18 2015-11-04 Karl Tryggvason Antibodies against domains of laminin-332
EP2198884A1 (en) 2008-12-18 2010-06-23 Centre National de la Recherche Scientifique (CNRS) Monoclonal antibodies directed against LG4-5 domain of alpha3 chain of human laminin-5
US9302005B2 (en) 2013-03-14 2016-04-05 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
WO2015050663A1 (en) 2013-10-01 2015-04-09 Mayo Foundation For Medical Education And Research Methods for treating cancer in patients with elevated levels of bim
WO2015179654A1 (en) * 2014-05-22 2015-11-26 Mayo Foundation For Medical Education And Research Distinguishing antagonistic and agonistic anti b7-h1 antibodies
US10517875B2 (en) 2014-07-23 2019-12-31 Mayo Foundation for Medical Engineering and Research Targeting DNA-PKcs and B7-H1 to treat cancer
US10875923B2 (en) 2015-10-30 2020-12-29 Mayo Foundation For Medical Education And Research Antibodies to B7-H1

Also Published As

Publication number Publication date
WO2000026342A1 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
AU5493201A (en) Method for introduction of molecules into cells
AU2193500A (en) Methods of preparing prismatic cells and prismatic cells prepared by such methods
AU1163700A (en) Method for eliminating static electricity
AU3026399A (en) An enzymatic oil-degumming process
AU1824600A (en) Low oxygen culturing of cells
AU1610299A (en) Method of cancer cell detection
AU6111699A (en) Novel method and compounds
AU5170900A (en) Cell proliferation inhibitors
AU6266398A (en) Method of preparing electrochemical cells
AU3769097A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU1329700A (en) Method of interfering with cell proliferation
AU4040499A (en) Electrochemical cell
AU2832399A (en) B cell inhibitors
AU5124699A (en) Molecules associated with cell proliferation
AU4697600A (en) Methods for increasing t cell proliferation
AU7638498A (en) Cyanoguanidines as cell proliferation inhibitors
AU6083898A (en) Method for the manufacture of photovoltaic cell
AUPO235996A0 (en) Method of cell culture
AU1563900A (en) Depositing method and arrangement
AU2590399A (en) Method of promoting hepatic cell proliferation
EP1038027A4 (en) Decreasing cell proliferation by decreasing levels of pp5
AU6634298A (en) Biosensor for cells
AU3459497A (en) Cancer cell proliferation inhibitors
AUPO129496A0 (en) Photoelectrochemical cell
AU7625600A (en) Electrochemical cell and cell assembly process

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase